## Abstract We report on a 56βyearβold woman with muscleβspecific receptor tyrosine kinase (MuSK) antibodyβpositive myasthenia with predominant bulbar symptoms and respiratory insufficiency. Conventional immunosuppression (prednisolone, azathioprine, mycophenolate mofetil) could not maintain the cl
Successful treatment of myasthenia gravis with tacrolimus
β Scribed by Amelia Evoli; Chiara Di Schino; Francesca Marsili; Chiara Punzi
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 152 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Acute treatment of myasthenic crisis with immunoadsorption (IA) or plasma exchange is well established. The efficiency of chronic apheresis therapy in myasthenia gravis (MG), however, and its efficacy in reducing concomitant potentially harmful immunosuppressive therapy, is unknown. We treated 13 pa
We report a patient with myasthenia gravis (MG) who had marked clinical benefit in response to treatment with mycophenolate mofetil as documented by serial quantitative measures of strength and muscle fatigue. Our patient had experienced either adverse side effects or a suboptimal response to the us
natural history of diabetic neuropathy. If sensory and autonomic features of diabetic neuropathy prove to be substantially irreversible-no clinical improvement was seen in the most recent trial of tight glucose control undertaken at the Mayo Clinic (F. J. Service et al)-much more attention will have